Targeting the MTF2–MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to ChemotherapyHarinad B. Maganti, William L. Stanford, Mitchell Sabloff et al.|Cancer Discovery|2018Cited by 57
Extended Material and Methods from Targeting the MTF2–MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to ChemotherapyHarinad B. Maganti, William L. Stanford, Hani Jrade et al.|Unknown|2023Cited by 0
Supplementary figures and legends from Targeting the MTF2–MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to ChemotherapyHarinad B. Maganti, William L. Stanford, Hani Jrade et al.|Unknown|2023Cited by 0
Supplementary Tables 1-2, 4-6, 9-11 from Targeting the MTF2–MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to ChemotherapyHarinad B. Maganti, William L. Stanford, Hani Jrade et al.|Unknown|2023Cited by 0
Supplementary Tables 3, 7-8 from Targeting the MTF2–MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to ChemotherapyHarinad B. Maganti, William L. Stanford, Hani Jrade et al.|Unknown|2023Cited by 0